Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4095)
All Articles published online
|
Jun 15, 2003 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li MY, Deng H, Zhao JM, Dai D, Tan XY. PPARγ pathway activation results in apoptosis and COX-2 inhibition in HepG2 cells. World J Gastroenterol 2003; 9(6): 1220-1226 [PMID: 12800228 DOI: 10.3748/wjg.v9.i6.1220] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v9/i6/1220.htm |
| Number | Citing Articles |
| 1 |
Belinda Knight, Bu B. Yeap, George C. Yeoh, John K. Olynyk. Inhibition of adult liver progenitor (oval) cell growth and viability by an agonist of the peroxisome proliferator activated receptor (PPAR) family member γ, but not α or δ. Carcinogenesis 2005; 26(10): 1782 doi: 10.1093/carcin/bgi138
|
| 2 |
Geneviève Drouin, Annie Douillette, Pierre Lacasse, Benoit Paquette. Effet radiosensibilisateur de l'acide linoléique conjugué chez les cellules cancéreuses du sein MCF-7 et MDA-MB-231. Canadian Journal of Physiology and Pharmacology 2004; 82(2): 94 doi: 10.1139/y04-003
|
| 3 |
Cai-Yan Zhao, Ling-Ling Jiang, Li Li, Zhuo-Jun Deng, Bao-Li Liang, Jian-Mei Li. Peroxisome proliferator activated receptor-γ in pathogenesis of experimental fatty liver disease. World Journal of Gastroenterology 2004; 10(9): 1329-1332 doi: 10.3748/wjg.v10.i9.1329
|
| 4 |
Kenichi Harada, Kumiko Isse, Takashi Kamihira, Shinji Shimoda, Yasuni Nakanuma. Th1 cytokine–induced downregulation of PPARγ in human biliary cells relates to cholangitis in primary biliary cirrhosis†. Hepatology 2005; 41(6): 1329 doi: 10.1002/hep.20705
|
| 5 |
Hajime Nozawa, Wakako Nakao, Feng Zhao, Keiji Kondo. Dietary supplement of isohumulones inhibits the formation of aberrant crypt foci with a concomitant decrease in prostaglandin E2 level in rat colon. Molecular Nutrition & Food Research 2005; 49(8): 772 doi: 10.1002/mnfr.200500027
|
| 6 |
Saswati Hazra, Katherine A. Peebles, Sherven Sharma, Jenny T. Mao, Steven M. Dubinett, Dipak Panigrahy. The Role of PPARγ in the Cyclooxygenase Pathway in Lung Cancer. PPAR Research 2008; 2008(1) doi: 10.1155/2008/790568
|
| 7 |
Suniket V. Fulzele, Abhijit Chatterjee, Madhu Sudhan Shaik, Tanise Jackson, Mandip Singh. Inhalation Delivery and Anti-tumor Activity of Celecoxib in Human Orthotopic Non-Small Cell Lung Cancer Xenograft Model. Pharmaceutical Research 2006; 23(9): 2094 doi: 10.1007/s11095-006-9074-6
|
| 8 |
Takayuki Ohshima, Hiroshi Koga, Kunitada Shimotohno. Transcriptional Activity of Peroxisome Proliferator-activated Receptor γ Is Modulated by SUMO-1 Modification. Journal of Biological Chemistry 2004; 279(28): 29551 doi: 10.1074/jbc.M403866200
|
| 9 |
Yukiko K. Nakamura, Stanley T. Omaye. Vitamin E-modulated gene expression associated with ROS generation. Journal of Functional Foods 2009; 1(3): 241 doi: 10.1016/j.jff.2009.02.002
|
| 10 |
ShouWei Han, Jesse Roman. Suppression of prostaglandin E2 receptor subtype EP2 by PPARγ ligands inhibits human lung carcinoma cell growth. Biochemical and Biophysical Research Communications 2004; 314(4): 1093 doi: 10.1016/j.bbrc.2004.01.007
|
| 11 |
Jiawei Chen, Dayuan Li, Xingjian Zhang, Jawahar L. Mehta. Tumor Necrosis Factor-α-Induced Apoptosis of Human Coronary Artery Endothelial Cells: Modulation by the Peroxisome Proliferator-Activated Receptor-γ Ligand Pioglitazone. Journal of Cardiovascular Pharmacology and Therapeutics 2004; 9(1): 35 doi: 10.1177/107424840400900i106
|
| 12 |
Wei Cui, Chang-Hong Yu, Ke-Qin Hu.
In vitro and In vivo Effects and Mechanisms of Celecoxib-Induced Growth Inhibition of Human Hepatocellular Carcinoma Cells. Clinical Cancer Research 2005; 11(22): 8213 doi: 10.1158/1078-0432.CCR-05-1044
|
| 13 |
Ivan Borbath, Yves Horsmans, Dipak Panigrahy. The Role of PPARγ in Hepatocellular Carcinoma. PPAR Research 2008; 2008(1) doi: 10.1155/2008/209520
|
| 14 |
M. Sánchez-Hidalgo, A.R. Martín, I. Villegas, C. Alarcón De La Lastra. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces chronic colonic inflammation in rats. Biochemical Pharmacology 2005; 69(12): 1733 doi: 10.1016/j.bcp.2005.03.024
|
| 15 |
Kenneth K.W. To, William K.K. Wu, Herbert H.F. Loong. PPARgamma agonists sensitize PTEN-deficient resistant lung cancer cells to EGFR tyrosine kinase inhibitors by inducing autophagy. European Journal of Pharmacology 2018; 823: 19 doi: 10.1016/j.ejphar.2018.01.036
|
| 16 |
Hidenori Haruna, Toshiaki Shimizu, Yoshikazu Ohtsuka, Yukiko Yarita, Tohru Fujii, Takahiro Kudo, Yuichiro Yamashiro. Expression of COX‐1, COX‐2, and PPAR‐γ in the gastric mucosa of children with Helicobacter pylori infection. Pediatrics International 2008; 50(1): 1 doi: 10.1111/j.1442-200X.2007.02504.x
|
| 17 |
Nicole Wagner, Kay-Dietrich Wagner. Peroxisome Proliferator-Activated Receptors and the Hallmarks of Cancer. Cells 2022; 11(15): 2432 doi: 10.3390/cells11152432
|
| 18 |
Guobin He, You Me Sung, Susan M. Fischer. Troglitazone induction of COX-2 expression is dependent on ERK activation in keratinocytes. Prostaglandins, Leukotrienes and Essential Fatty Acids 2006; 74(3): 193 doi: 10.1016/j.plefa.2005.12.001
|
| 19 |
Markus Schwab, Veerle Reynders, Sandra Ulrich, Nadine Zahn, Jürgen Stein, Oliver Schröder. PPARγ is a key target of butyrate-induced caspase-3 activation in the colorectal cancer cell line Caco-2. Apoptosis 2006; 11(10): 1801 doi: 10.1007/s10495-006-9788-2
|
| 20 |
Ann K.Y. To, George G. Chen, Ursula P.F. Chan, Caiguo Ye, Jing P. Yun, Rocky L.K. Ho, Art Tessier, Juanita L. Merchant, Paul B.S. Lai. ZBP-89 enhances Bak expression and causes apoptosis in hepatocellular carcinoma cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2011; 1813(1): 222 doi: 10.1016/j.bbamcr.2010.09.005
|
| 21 |
Anett Klopotek, Frank Hirche, Klaus Eder. PPARγ Ligand Troglitazone Lowers Cholesterol Synthesis in HepG2 and Caco-2 Cells via a Reduced Concentration of Nuclear SREBP-2. Experimental Biology and Medicine 2006; 231(8): 1365 doi: 10.1177/153537020623100810
|
| 22 |
Chiara Russo, Margherita Lavorgna, Roberta Nugnes, Elena Orlo, Marina Isidori. Comparative assessment of antimicrobial, antiradical and cytotoxic activities of cannabidiol and its propyl analogue cannabidivarin. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-01975-z
|
| 23 |
Priyadarshini Raman, Barbara L. F. Kaplan, Jerry T. Thompson, John P. Vanden Heuvel, Norbert E. Kaminski. 15-Deoxy-Δ12,14-prostaglandin J2-Glycerol Ester, a Putative Metabolite of 2-Arachidonyl Glycerol, Activates Peroxisome Proliferator Activated Receptor γ. Molecular Pharmacology 2011; 80(1): 201 doi: 10.1124/mol.110.070441
|
| 24 |
Saswati Hazra, Raj K. Batra, Hsin H. Tai, Sherven Sharma, Xiaoyan Cui, Steven M. Dubinett. Pioglitazone and Rosiglitazone Decrease Prostaglandin E2 in Non–Small-Cell Lung Cancer Cells by Up-Regulating 15-Hydroxyprostaglandin Dehydrogenase. Molecular Pharmacology 2007; 71(6): 1715 doi: 10.1124/mol.106.033357
|
| 25 |
Yan Wu, Sun-Wei Guo. Peroxisome proliferator-activated receptor-gamma and retinoid X receptor agonists synergistically suppress proliferation of immortalized endometrial stromal cells. Fertility and Sterility 2009; 91(5): 2142 doi: 10.1016/j.fertnstert.2008.04.012
|
| 26 |
Emmanuelle Berger, Nathalie Vega, Hubert Vidal, Alain Geloën. Gene network analysis leads to functional validation of pathways linked to cancer cell growth and survival. Biotechnology Journal 2012; 7(11): 1395 doi: 10.1002/biot.201200188
|
| 27 |
Hitoshi Ishiguro, Yukari Ishiguro, Yoshinobu Kubota, Hiroji Uemura. Regulation of prostate cancer cell growth and PSA expression by angiotensin II receptor blocker with peroxisome proliferator‐activated receptor gamma ligand like action. The Prostate 2007; 67(9): 924 doi: 10.1002/pros.20571
|
| 28 |
Wei Cui, Shirley X. Hu, Zhen-Ya Tang, Ke-Qin Hu. In-vivo effects and mechanisms of celecoxib-reduced growth of cyclooxygenase-2 (COX-2)-expressing versus COX-2-deleted human HCC xenografts in nude mice. Anti-Cancer Drugs 2008; 19(9): 891 doi: 10.1097/CAD.0b013e32830ef8ca
|
| 29 |
Katherine A Peebles, Jay M Lee, Jenny T Mao, Saswati Hazra, Karen L Reckamp, Kostyantyn Krysan, Mariam Dohadwala, Eileen L Heinrich, Tonya C Walser, Xiaoyan Cui, Felicita E Baratelli, Edward Garon, Sherven Sharma, Steven M Dubinett. Inflammation and lung carcinogenesis: applying findings in prevention and treatment. Expert Review of Anticancer Therapy 2007; 7(10): 1405 doi: 10.1586/14737140.7.10.1405
|
| 30 |
Yan Zhang, Yi Ba, Chang Liu, Guoxun Sun, Li Ding, Songyuan Gao, Jihui Hao, Zhentao Yu, Junfeng Zhang, Ke Zen, Zhongsheng Tong, Yang Xiang, Chen-Yu Zhang. PGC-1α induces apoptosis in human epithelial ovarian cancer cells through a PPARγ-dependent pathway. Cell Research 2007; 17(4): 363 doi: 10.1038/cr.2007.11
|
| 31 |
I. Borbath, I. Leclercq, P. Moulin, C. Sempoux, Y. Horsmans. The PPARgamma agonist pioglitazone inhibits early neoplastic occurrence in the rat liver. European Journal of Cancer 2007; 43(11): 1755 doi: 10.1016/j.ejca.2007.05.005
|
| 32 |
Mei Ming, Jie-Ping Yu, Xiang-Zhi Meng, Yan-Hong Zhou, Hong-Gang Yu, He-Sheng Luo. Effect of ligand troglitazone on peroxisome proliferator-activated receptor γ expression and cellular growth in human colon cancer cells. World Journal of Gastroenterology 2006; 12(45): 7263-7270 doi: 10.3748/wjg.v12.i45.7263
|
| 33 |
Hong-Liang Liang, Qin Ouyang. A clinical trial of combined use of rosiglitazone and 5-aminosalicylate for ulcerative colitis. World Journal of Gastroenterology 2008; 14(1): 114-119 doi: 10.3748/wjg.14.114
|
| 34 |
Marina Sánchez-Hidalgo, Antonio Ramon Martín, Isabel Villegas, Catalina Alarcón de la Lastra. Rosiglitazone, a PPARγ ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats. European Journal of Pharmacology 2007; 562(3): 247 doi: 10.1016/j.ejphar.2007.01.047
|
| 35 |
Jing Wang, Li Yuan, Haifang Xiao, Chan Wang, Chunxia Xiao, Yutang Wang, Xuebo Liu. A novel mechanism for momordin Ic-induced HepG2 apoptosis: involvement of PI3K- and MAPK-dependent PPARγ activation. Food & Function 2014; 5(5): 859 doi: 10.1039/c3fo60558b
|
| 36 |
Hsiao-Chi Chen, Hui-Tzu Hsu, Jing-Wen Weng, Yuh-Fang Chang, Cheng-Yuan Hsia, Hsin-Chen Lee, Chin-Wen Chi. Combined effect of honokiol and rosiglitazone on cell growth inhibition through enhanced G0/G1 phase arrest in hepatoma cells. Journal of the Chinese Medical Association 2016; 79(8): 415 doi: 10.1016/j.jcma.2016.03.003
|
| 37 |
Fausto Bogazzi, Federica Ultimieri, Francesco Raggi, Dania Russo, Renato Vanacore, Chiara Guida, Sandra Brogioni, Chiara Cosci, Maurizio Gasperi, Luigi Bartalena, Enio Martino. Growth Hormone Inhibits Apoptosis in Human Colonic Cancer Cell Lines: Antagonistic Effects of Peroxisome Proliferator Activated Receptor-γ Ligands. Endocrinology 2004; 145(7): 3353 doi: 10.1210/en.2004-0225
|
| 38 |
Siyan Chen, Chong Liu, Xiaoqian Wang, Xiujin Li, Yanling Chen, Nanhong Tang. 15-Deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2) promotes apoptosis of HBx-positive liver cells. Chemico-Biological Interactions 2014; 214: 26 doi: 10.1016/j.cbi.2014.02.009
|
| 39 |
Dana J. Herrigel, Rebecca A. Moss. Diabetes Mellitus as a Novel Risk Factor for Gastrointestinal Malignancies. Postgraduate Medicine 2014; 126(6): 106 doi: 10.3810/pgm.2014.10.2825
|
| 40 |
Seo‑Na Chang, Ji Lee, Hanseul Oh, Ukjin Kim, Bokyeong Ryu, Jae‑Hak Park. Troglitazone inhibits the migration and invasion of PC‑3 human prostate cancer cells by upregulating E‑cadherin and glutathione peroxidase 3. Oncology Letters 2018; doi: 10.3892/ol.2018.9278
|
| 41 |
Radina Kostadinova, Franziska Boess, Dawn Applegate, Laura Suter, Thomas Weiser, Thomas Singer, Brian Naughton, Adrian Roth. A long-term three dimensional liver co-culture system for improved prediction of clinically relevant drug-induced hepatotoxicity. Toxicology and Applied Pharmacology 2013; 268(1): 1 doi: 10.1016/j.taap.2013.01.012
|
| 42 |
Gholamreza Houshmand, Mohammad Taghi Mansouri, Bahareh Naghizadeh, Ali Asghar Hemmati, Mahmoud Hashemitabar. Potentiation of indomethacin-induced anti-inflammatory response by pioglitazone in carrageenan-induced acute inflammation in rats: Role of PPARγ receptors. International Immunopharmacology 2016; 38: 434 doi: 10.1016/j.intimp.2016.06.027
|